Developmental trajectories in infants and pre-school children with Neurofibromatosis 1
Hannah Slevin,Fiona Kehinde,Jannath Begum-Ali,Ceri Ellis,Emma Burkitt-Wright,Jonathan Green,Mark H. Johnson,Greg Pasco,Tony Charman,Emily J. H. Jones,Shruti Garg,the EDEN-STAARS team,Mary Agyapong,Tessel Bazelmans,Leila Dafner,Mutluhan Ersoy,Teodora Gliga,Amy Goodwin,Rianne Haartsen,Hanna Halkola,Alexandra Hendry,Rebecca Holman,Sarah Kalwarowsky,Sarah Lloyd-Fox,Luke Mason,Nisha Narvekar,Laura Pirazzoli,Chloë Taylor,Grace Vassallo,Judith Eelloo,D. Gareth Evans,Siobhan West,Eileen Hupton,Louise Robinson,Neeta Lakhani,Brian Wilson,Deborah Osio,Charles Shaw-Smith,Natalie Canham,Saba Sharif
DOI: https://doi.org/10.1186/s13229-024-00621-5
2024-10-16
Molecular Autism
Abstract:Children with Neurofibromatosis 1 (NF1) show cognitive, behavioural and social differences compared to their peers. However, the age and sequence at which these differences begin to emerge is not fully understood. This prospective cohort study examines the cognitive, behavioural, ADHD trait and autism symptom development in infant and pre-school children with NF1 compared with typically developing (TD) children without a family history of neurodevelopmental conditions.
genetics & heredity,neurosciences